Filing focuses on generic drug costs levied by pharmacies absorbed by the pharmacy giant.
In 2013, J. Douglas Strauser, a pharmacist, filed a whistleblower lawsuit against Stephen L. LaFrance Holdings Inc. and Walgreens, alleging that they overcharged Medicaid for generic drugs by not giving the government the best price. Stephen L. LaFrance Holdings was the owner and operator of a pharmacy chain in seven states that purchased by Walgreens in 2012 for over $400 million. A few pharmacies that were not acquired by Walgreens are also defendants in the whistleblower suit.
According to the complaint, the pharmacies were offering cash-paying customers generic drugs for $4, but charged Medicaid higher prices for the same drugs. This program was allegedly set up to compete with Walmart’s $4 generic drug pricing for 30-day supplies of common medications, but it only applied to customers who were not insured. However, Walmart charged Medicaid the same price that it charged these customers.
Medicaid bases the amount it pays for drugs on “usual and customary” prices reported by pharmacies. The suit alleges that the rate is commonly understood in the industry to mean the price that cash-paying customers pay for drugs. According to the complaint, the pharmacies were instructed not to advertise the program out of fear of getting detected by state regulators. Much of the conduct occurred prior to Walgreens’ acquisition of the pharmacies. The practice ended when Walgreens converted the acquired pharmacies onto a new software system, which informed Medicaid programs of the low prices offered to uninsured customers.
Last year, the government declined to intervene in the whistleblower suit, and various defendants quickly filed motions to dismiss against the whistleblower who chose to continue litigating his claims without the U.S. Department of Justice or the attorneys general for the states of New Jersey, Oklahoma, and Tennessee. On March 7, whistleblower Strauser defeated the motions to dismiss when a federal judge allowed his case to move forward. In denying the motions, the Court noted six other suits with nearly identical allegations that all survived such motions. The court also dispatched defendants’ argument that “usual and customary” is an ambiguous phrase open to interpretation, calling the defense argument “in tension with the plain meaning of words.”
The case now moves into discovery, and we will keep RACmonitor readers posted on future developments.
This suit is an excellent example of how whistleblower incentive programs like the qui tam provisions of the state and federal False Claims Acts can attract extremely qualified and credible persons to file suit on the government’s behalf. J. Douglas Strauser, the whistleblower, was a pharmacist for almost 40 years before he filed the whistleblower suit. He operated several of his own pharmacies, selling the last one he operated to one of the defendants in 2008. According to the complaint, Mr. Strauser pointed out the alleged fraud to several executives in dozens of conversations before filing this suit. He has also founded a disaster-relief charitable organization, served as the mayor of his Missouri town, acted as local school board president for over a decade, and is on the board of directors of a local bank.
The expertise Strauser brought to the case is obvious from a review of the complaint and his recent survival of the motions to dismiss.
As Washington political gridlock keeps the nation in yet another federal shutdown, hospitals across Florida are bracing for ripple effects that could strain budgets and
As we conclude National Case Management Week 2025 with the theme of “Guiding Journeys,” we are making a point of celebrating case management professionals who
Please log in to your account to comment on this article.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
